All filters
Slidesets
Big data vs. the individual liver - regulatory perspective- Robert Schuck, PharmD, PhD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Serum GP73 as a surrogate biomarker of significant liver fibrosis and cirrhosis in NAFLD- Fengmin Lu
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Future scenarios of algorithm building- Tom Travison, PhD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
A precision medicine approach to comprehensive NAFLD diagnosis via metabolomics-based liquid biopsy- Pablo Ortiz
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Next-Generation Sequencing (NGS) of two independent cohorts identifies eleven circulating miRNAs for diagnosis of NASH and fibrosis- Sven Francque
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Navigating NASH biomarkers: From discovery to clinical practice- John Sninsky, PhD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Integrated assessment of diabetes, cardiovascular and liver risks and its potential application in the clinical management of NAFLD- Arun Sanyal, MD, MBBS
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
(Abstract) Predicting Antiviral Drug Toxicity Using Contractility Analysis Of Human IPSC Derived Cardiomyocytes | Brian D. Herman
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
State of the Art Lecture: What Do We Really Know About Dengue Viruses | Oscar Perng, PhD
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
Global Burden and Novel Treatment of Noroviruses | Ladislau Kovari, PhD
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
Zika Neuropathies Beyond Microcephaly | Maurício Lacerda Nogueira, MD, PhD
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
HIV Knowledge and Hope in Africa | Carol A. Harris, MD
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
Rapid Zika Detection for Resource-Limited Regions | Mark Sharkey, PhD
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
(Abstract) In Silico Approaches Towards Broadly Active Flavivirus Protease Inhibitors | Bryan D. Cox
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
HIV-1 Macrophage Reservoirs: Lessons from Host Macrophage Specific Restriction Factor, SAMHD1 | Baek Kim, PhD
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
David Barry DART Achievement Award Lecture: The Discovery of SIV and Development of Monkey Models for the Study of HIV/ AIDS | Ronald Desrosiers, PhD
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
(Abstract) Differential responses of memory CD4+ T cell subsets to HIV latency reversing agents | D. Kulpa
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
(Abstract) HIV-1 dynamics under integrase inhibitor therapy suggests a subset of cells with slow integration | R.M. Ribeiro
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
Impact of Jak Inhibitors on HIV Reservoir Maintenance, Lifespan and Expansion in Primary T Cells and Macrophages | Christina Gavegnano, PhD
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
Current Clinical Therapies for HIV Remission | David Margolis, MD
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
(Abstract) Anti–HIV drug candidate abx464 prevents intestinal inflammation by producing IL22 in activated macrophages | J. Tazi
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
Gertrude Elion Distinguished Lecturer Award Lecture Stories on Scientific Discoveries that Transformed HIV into a Manageable Disease | Mark Wainberg, MD
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
(Abstract) Development of a protease inhibitor-based single-tablet complete HIV-1 regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (DCFTAF) | B. Baugh
Presented at:
HIV DART and Emerging Viruses 2016